Efficacy of granulocyte-macrophage colony-stimulating factor on the survival of ischaemic skin flaps in rats. 2005

Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
Department of General Surgery, Ankara Oncology Education and Research Hospital, Turkey. bekirkuru@hotmail.com

Our objective was to find out whether granulocyte-macrophage colony-stimulating factor (GM-CSF) improves the survival of skin flaps in rats. Random skin flaps were raised in 30 male Sprague-Dawley rats, and recombinant GM-CSF 50 microg in 0.5 ml saline solution (n=15) or 0.5 ml saline solution alone (n=15) was injected intradermally into the area of the flap after it had been raised. Surviving areas were measured after seven days, and the median area surviving in the group treated with GM-CSF was greater than that in the control group (728 mm2 (range 565-1120) compared with 985 mm2 (range 636-1368), p=0.005). These results suggest that in this model, GM-CSF given postoperatively improves the viability of ischaemic skin flaps.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013524 Surgical Flaps Tongues of skin and subcutaneous tissue, sometimes including muscle, cut away from the underlying parts but often still attached at one end. They retain their own microvasculature which is also transferred to the new site. They are often used in plastic surgery for filling a defect in a neighboring region. Island Flap,Island Flaps,Flap, Surgical,Flaps, Surgical,Pedicled Flap,Surgical Flap,Flap, Island,Flap, Pedicled,Flaps, Island,Flaps, Pedicled,Pedicled Flaps
D014022 Tissue Survival The span of viability of a tissue or an organ. Organ Survival,Organ Viability,Tissue Viability,Survival, Organ,Survival, Tissue,Viability, Organ,Viability, Tissue
D016178 Granulocyte-Macrophage Colony-Stimulating Factor An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. CSF-GM,Colony-Stimulating Factor, Granulocyte-Macrophage,GM-CSF,Histamine-Producing Cell-Stimulating Factor,CSF-2,TC-GM-CSF,Tumor-Cell Human GM Colony-Stimulating Factor,Cell-Stimulating Factor, Histamine-Producing,Colony Stimulating Factor, Granulocyte Macrophage,Granulocyte Macrophage Colony Stimulating Factor,Histamine Producing Cell Stimulating Factor,Tumor Cell Human GM Colony Stimulating Factor
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
August 2009, Journal of plastic, reconstructive & aesthetic surgery : JPRAS,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
July 1992, The New England journal of medicine,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
July 1992, The New England journal of medicine,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
January 1990, Immunology series,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
January 1990, Biotherapy (Dordrecht, Netherlands),
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
July 1991, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
November 2005, Journal of the American College of Cardiology,
Bekir Kuru, and Soykan Dinc, and Orhan Elitok, and Mehmet Ali Gulcelik, and Haluk Alagol
May 1997, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!